Found: 1

Select item for more details and to access through your institution.

  • Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 6, p. 1656, doi. 10.1007/s10637-021-01134-1
    By:
    • Ashkar, Ryan;
    • Feldman, Darren R.;
    • Adra, Nabil;
    • Zaid, Mohammad Abu;
    • Funt, Samuel A.;
    • Althouse, Sandra K.;
    • Perkins, Susan M.;
    • Snow, Christin I.;
    • Lazzara, Kayla M.;
    • Sego, Lina M.;
    • Quinn, David I.;
    • Hanna, Nasser H.;
    • Einhorn, Lawrence H.;
    • Albany, Costantine
    Publication type:
    Article